• Explore /
  • Poster
  • / Cardiac safety and efficacy for patients with early-stage breast cancer treated with pegylated liposomal doxorubicin (PLD) or doxorubicin.

Cardiac safety and efficacy for patients with early-stage breast cancer treated with pegylated liposomal doxorubicin (PLD) or doxorubicin.

Abstract Poster

Authors

null

Lichen Tang

Department of Breast Surgery, Fudan University Shanghai Cancer Center; Cancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Lichen Tang , Min He , Jiong Wu , Zhonghua Wang , Guangyu Liu , Keda Yu , Cuizhi Geng , Zhimin Fan , Rui Ling , Guangdong Qiao , Li Cai , Ting Luo , Feng Jin , Haibo Wang , Anqin Zhang , Hongwei Zhang , Xiaohua Zeng , Xiaojia Wang , Ming Jiang , Shao Zhimin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT03949634

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 550)

DOI

10.1200/JCO.2023.41.16_suppl.550

Abstract #

550

Poster Bd #

380

Abstract Disclosures

Similar Posters

First Author: Rui Wang

First Author: Susan Faye Dent

First Author: Rebecca Arielle Shatsky

First Author: Kay T Yeung